UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000008321
Receipt No. R000009536
Official scientific title of the study Prospective randomized trial for optimizing medical therapy after coronary stenitng
Date of disclosure of the study information 2012/07/03
Last modified on 2017/02/27 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Prospective randomized trial for optimizing medical therapy after coronary stenitng
Title of the study (Brief title) Calcium-Beta
Region
Japan

Condition
Condition Coronary artery disease (CAD)
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 The study will test whether calcium channel blockers would provide equal or additional benefit compared to standard beta-blocker therapy in Japanese patients who underwent stenting of single vessel lesion.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Presence of Acetylcholine induced coronary vasospasm 9 month after PCI
Key secondary outcomes All cause death
MACEE: acute myocardial infarction, stable or unstable angina, any coronary revascularization procedure, or cerebrovascular accident

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 calcium channel blockers (CCBs)
Interventions/Control_2 Beta blockers
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.Patients with stable/unstable angina or silent ischemia who underwent PCI with everolimus eluting stent.
2.Single vessel disease with deployment of 3 stents or less.
3.Patients must be 20 years of age or more.
Key exclusion criteria 1.Stent restenosis or previous bypass surgery.
2.Previous diagnosis of vasospasmic angina within 1 years and/or on treatment.
3.Previous PCI within 1 years.
4.An event of acute myocardial infarction within 7 days.
5.Left main disease.
6.Left ventricular ejection fraction of less than 35%.
7.Previous Pacemaker Implant or AV block of more than 1st degree.
8.SBP less than 100 or HR less than 60 prior to PCI.
9.Renal failure (Cr more than 2.0mg/dl or on hemodialysis)
10.Liver failure (eg. cirrhosis)
11.Reversible obstructive lung disease
12.Diagnosis of malignancy within 5 years
13.Pregnancy
Target sample size 100

Research contact person
Name of lead principal investigator Shun Kohsaka
Organization Keio University, School of Medicine
Division name Division of Cardiology
Address 35 Shinanomachi Shinjuku Tokyo Japan 160-8582
TEL 03-3353-1211
Email sk@keio.jp

Public contact
Name of contact person Shun Kohsaka
Organization Keio University, School of Medicine
Division name Division of Cardiology
Address 35 Shinanomachi Shinjuku Tokyo Japan 160-8582
TEL 03-3353-1211
Homepage URL
Email sk@keio.jp

Sponsor
Institute Keio University, School of Medicine
Institute
Department

Funding Source
Organization Pfizer Japan Inc.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization JAPAN

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 07 Month 03 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2012 Year 05 Month 20 Day
Anticipated trial start date
2012 Year 06 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 07 Month 02 Day
Last modified on
2017 Year 02 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009536